ZORZON, MARINO
 Distribuzione geografica
Continente #
NA - Nord America 7.118
AS - Asia 3.828
EU - Europa 3.006
SA - Sud America 541
AF - Africa 64
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 3
AN - Antartide 1
Totale 14.571
Nazione #
US - Stati Uniti d'America 7.064
SG - Singapore 1.478
CN - Cina 893
UA - Ucraina 790
IT - Italia 522
BR - Brasile 436
HK - Hong Kong 391
VN - Vietnam 312
SE - Svezia 305
KR - Corea 287
FI - Finlandia 275
FR - Francia 252
TR - Turchia 229
GB - Regno Unito 191
PL - Polonia 126
RU - Federazione Russa 118
IE - Irlanda 116
BG - Bulgaria 115
DE - Germania 89
IN - India 60
BD - Bangladesh 38
AR - Argentina 29
NL - Olanda 29
IQ - Iraq 28
BE - Belgio 21
AT - Austria 20
CA - Canada 20
MX - Messico 19
JP - Giappone 18
ZA - Sudafrica 18
MA - Marocco 17
ID - Indonesia 16
PY - Paraguay 15
EC - Ecuador 14
CO - Colombia 13
PK - Pakistan 13
IR - Iran 10
JO - Giordania 10
CL - Cile 9
VE - Venezuela 9
AU - Australia 8
CH - Svizzera 8
PE - Perù 8
EG - Egitto 7
PH - Filippine 7
ES - Italia 6
AL - Albania 5
KZ - Kazakistan 5
TN - Tunisia 5
UZ - Uzbekistan 5
BO - Bolivia 4
DZ - Algeria 4
MY - Malesia 4
NP - Nepal 4
OM - Oman 4
SN - Senegal 4
UY - Uruguay 4
DK - Danimarca 3
JM - Giamaica 3
KE - Kenya 3
PA - Panama 3
PS - Palestinian Territory 3
PT - Portogallo 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BY - Bielorussia 2
ET - Etiopia 2
EU - Europa 2
GR - Grecia 2
HN - Honduras 2
LT - Lituania 2
NZ - Nuova Zelanda 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AQ - Antartide 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GE - Georgia 1
GT - Guatemala 1
HR - Croazia 1
IL - Israele 1
LB - Libano 1
LK - Sri Lanka 1
ME - Montenegro 1
NG - Nigeria 1
NI - Nicaragua 1
PR - Porto Rico 1
RO - Romania 1
TH - Thailandia 1
UG - Uganda 1
ZM - Zambia 1
Totale 14.571
Città #
Singapore 850
Fairfield 748
Jacksonville 674
Woodbridge 640
Ashburn 592
Wilmington 417
Houston 410
Ann Arbor 401
Hong Kong 387
Chandler 341
Seattle 298
Hefei 294
San Jose 287
Seoul 285
Cambridge 272
Princeton 228
Izmir 214
Beijing 200
Boardman 151
Chicago 145
Santa Clara 120
Sofia 115
Dublin 114
Zgierz 113
Columbus 105
Ho Chi Minh City 96
Lauterbourg 96
Buffalo 92
Milan 85
Hanoi 81
Dallas 80
Moscow 79
Los Angeles 76
The Dalles 69
San Diego 49
Verona 48
Helsinki 45
Dearborn 34
São Paulo 33
Bremen 23
Norwalk 23
Brussels 21
Frankfurt am Main 21
Trieste 21
Washington 21
New York 20
Venezia 16
Da Nang 15
Düsseldorf 14
Mumbai 14
Nuremberg 14
Tokyo 14
London 13
Rio de Janeiro 13
Brooklyn 12
Rome 12
Haiphong 11
Johannesburg 11
Phoenix 11
Warsaw 11
Auburn Hills 10
Chennai 10
Denver 10
Guangzhou 10
Casablanca 9
Munich 9
Nanjing 9
Tianjin 9
Amman 8
Brasília 8
Kunming 8
Toronto 8
Amsterdam 7
Baghdad 7
Belo Horizonte 7
Can Tho 7
Dhaka 7
Quito 7
Redondo Beach 7
Vienna 7
Barnet 6
Boston 6
Caracas 6
Hangzhou 6
Hải Dương 6
Jinan 6
Salvador 6
San Mateo 6
Shanghai 6
Zhengzhou 6
Augusta 5
Bexley 5
Biên Hòa 5
Bogotá 5
Carosino 5
Dalian 5
Leawood 5
New Delhi 5
Porto Alegre 5
Portsmouth 5
Totale 9.969
Nome #
Altered serum content of brain-derived neurotrophic factor isoforms in multiple sclerosis. 296
Functional MRI during the execution of a motor task in patients with multiple sclerosis and fatigue. 242
Optic Nerve and its Arterial-Venous Vascularization: An Ultrasonologic Study in Multiple Sclerosis Patients and Healthy Controls. 239
Bilingual aphasia and subcortical-cortical lesions. 231
Ultrasound findings of the optic nerve and its arterial venous system in multiple sclerosis patients with and without optic neuritis vs. healthy controls. 215
Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study. 201
Acute encephalopathy and polyneuropathy after disulfiram intoxication. 191
Interferon beta-1a slows progression of brain atrophy in relapsing-remitting multiple sclerosis predominantly by reducing gray matter atrophy. 187
MMP-9 microsatellite polymorphism and multiple sclerosis. 186
Acute akinesia, an unusual complication in Parkinson’s disease: a case report 186
Mielite recidivante:esordio clinico di neuromielite ottica? 183
Is gadolinium enhancement predictive of the development of brain atrophy in multiple sclerosis? A review of the literature. 178
CORRELATION OF SEXUAL DYSFUNCTION AND BRAIN MAGNETIC RESONANCE IMAGING IN MULTIPLE SCLEROSIS 177
Chronic bilateral electrical stimulation of the subthalamic nucleus for the treatment of advanced Parkinson's disease 177
HLA-DRB1*1501, -DQB1*0301, -DQB1*0302, -DQB1*0602, and -DQB1*0603 alleles are associated with more severe disease outcome on MRI in patients with multiple sclerosis. 176
A longitudinal study of quality of life and side effects in patients with Multiple Sclerosis treated with Interferon beta-1a. 175
Depressive symptoms and MRI changes in multiple sclerosis 171
HLA GENOTYPES AND DISEASE SEVERITY ASSESSED BY MAGNETIC RESONANCE IMAGING FINDINGS IN PATIENTS WITH MULTIPLE SCLEROSIS. 170
A longitudinal study of brain atrophy and cognitive disturbances in early phase of relapsing-remitting multiple sclerosis 167
Short-term brain atrophy changes in relapsing-remitting multiple sclerosis. 166
Gene-environment interactions between HLA B7/A2, EBV antibodies are associated with MRI injury in multiple sclerosis. 165
Immediate prognosis of primary intracerebral hemorrhage using an easy model for the prediction of survival. 164
Outcome of medication overuse headache after abrupt in-patient withdrawal. 163
Trigeminal neuralgia due to contralateral meningioma of the posterior cranial fossa. 159
SEXUAL DYSFUNCTION IN MULTIPLE SCLEROSIS. II. CORRELATION ANALYSIS 156
Positivity of cytomegalovirus antibodies predicts a better clinical and radiological outcome in multiple sclerosis patients. 156
Effect of intravenous methylprednisolone on the number, size and confluence of plaques in relapsing-remitting multiple sclerosis. 155
Effect of intravenous methylprednisolone in the number, size and confluence of plaques in relapsing-remitting multiple sclerosis. 155
Incidence and prevalence of myasthenia gravis in the county of the coast and Gorski kotar, Croatia, 1976 through 1996. 154
Long-term effects of intravenous high dose methylprednisolone pulses on bone mineral density in patients with multiple sclerosis. 153
Headache induced by Chronic substance use:analysis of medication overused and minimum dose required to induce headache. 150
Efficacia del mesoglicano nella terapia della placca ateromasica dei vasi epiaortici 148
Sexual dysfunction in multiple sclerosis: a 2-year follow-up study 148
SEXUAL DYSFUNCTION IN MULTIPLE SCLEROSIS. A CASE-CONTROL STUDY. I. FREQUENCY AND COMPARISON OF GROUPS 147
Proton magnetic resonance spectroscopy during transient global amnesia 147
Nontraumatic headache in the Emergency Department: a survey in the province of Trieste. 140
Aritmie cardiache ed ischemia cerebrale acuta. Studio con monitoraggio Holter 140
Clinical surveillance of patients with multiple sclerosis 139
Familial and environmental risk factors in Parkinson's disease: a case control study in North-East Italy. 138
Central nervous system atrophy in Multiple Sclerosis: Introduction. 137
OLFACTORY LOSS IN MULTIPLE SCLEROSIS 137
Effects of IV methylprednisolone on brain atrophy in relapsing-remitting MS 137
Case Report: Coexistence of SUNCT and Hypnic Headache in the Same Patient 137
Development of myasthenia gravis during interferon-alpha treatment for anti-HCV positive chronic hepatitis. 135
Effect of MRI coregistration on serial short-term brain volume changes in multiple sclerosis. 134
Risk factors of multiple sclerosis:a case-control study. 133
Sclerosi multipla in overlap con sindrome di Sjogren 133
MRI TECHNIQUES AND COGNITIVE IMPAIRMENT IN EARLY PHASE OF RELAPSING-REMITTING MULTIPLE SCLEROSIS 132
Prevalence of migraine in Croatia: a population-based survey. 130
Beta 2-microglobulin level is not a marker of disease activity in Multiple Sclerosis. 128
Incidence and prevalence of motor neuron disease in Coastal and Mountanious Regions, Croatia, 1984-1993. A preliminary survey. 128
Osteopontin gene haplotypes correlate with multiple sclerosis development and progression. 127
Transient global amnesia and transient ischemic attack. Natural history, vascular risk factors, and associated conditions. 127
Atrial fibrillation and acute ischemic cerebrovascular disease. Study of 500 cases of cerebral infarction and transient cerebral ischemic attacks 127
Epstein-Barr Virus is Associated with Gray Matter Atrophy in Multiple Sclerosis 127
Approccio multidisciplinare alla Sclerosi Multipla. SPSM-RIabilitazione 127
Sexual dysfunction in multiple sclerosis. A MRI, neurophysiological and urodynamic study 126
Migraine and tension-type headache in Croatia: a population-based survey of precipitating factors. 126
Concordance of carotid bruit and positivity of computerized digital angiography of the epiaortic vessels in carotid stenotico-occlusive pathology 125
Hyperglycemia at ischemic stroke onset as prognostic factor. 124
Depression and anxiety in multiple sclerosis. A clinical and MRI study in 95 subjectsJ 122
Cysts of the atlantoaxial joint: excellent long-term outcome after posterolateral surgical decompression. Report of two cases. 121
Treatment of multiple sclerosis. The present and the future. Study Group on Diagnosis and Therapy of Multiple Sclerosis 119
Aspetti epidemiologici e clinici dello stroke. 119
Persistent aura without infarction:description of the first case studied with both brain SPECT and perfusion MRI. 118
Reproducibility and accuracy of quantitative magnetic resonance imaging techniques of whole-brain atrophy measurement in multiple sclerosis. 118
Trattamento con cicli di megadosi di metilprednisolone in pazienti affetti da sclerosi multipla cronico-progressiva: valutazione clinica a tre anni 118
Hypnic headache:rapid and long-lasting response to prednisone in two new cases. 116
Magnetic resonance imaging techniques as predictors of cognitive impairment in multiple sclerosis 111
Donna e Sclerosi Multipla. I disturbi della sfera sessuale nelle pazienti con sclerosi multipla. 111
Proton magnetic resonance spectroscopy study of ischemia in intracerebral hemorrhage 109
Update sul Teriflunomide 109
THE USE OF STANDARDIZED INCIDENCE AND PREVALENCE RATES IN EPIDEMIOLOGICAL STUDIES ON MULTIPLE SCLEROSIS. A META-ANALYSIS STUDY 106
L'aderenza alla terapia nella sclerosi multipla. Il punto di vista del medico 106
Use of ticlopidine in patients with acute non-embolic cerebral infarcts 105
Diagnosi e gestione del paziente con sclerosi multipla. Il paziente CIS 104
Il management del paziente di nuova diagnosi. La comunicazione della diagnosi. 104
Side-effects and changes in systemic arterial pressure after administration of a single dose of lorazepam 100
Disabilità e Qualità della Vita nelle persone colpite da Sclerosi Multipla 100
Relationship between central nervous system atrophy and genetic-immunological markers in Multiple Sclerosis 99
La rieducazione equestre: una possibilità riabilitativa 99
Discordanza tra attività di malattia clinica e in risonanza magnetica 99
Increased density in the middle cerebral artery by nonenhanced computed tomography. Prognostic value in acute cerebral infarction. 98
Focus on:ECTRIMS e SIN 2006 97
Gaucher’s disease with Parkinson’s disease: Clinical and pathological aspects 96
The blood level of uric acid as a risk factor in transient cerebral ischemic attacks and in non-embolic acute cerebral infarct 94
Fumo di sigaretta e rischio d'insorgenza delle vasculopatie cerebrali acute di tipo ischemico 94
Fattori prognostici nell'emorragia cerebrale primitiva sopratentoriale 92
Terapia antiossidante nell’ictus ischemico acuto 92
Olfactory dysfunction and extent of white matter abnormalities in multiple sclerosis. A clinical and MRI study 91
Frontal parenchimal atrophy measures in multiple sclerosis. 90
SFAAT: Studio della fibrillazione atriale cronica non reumatica nell’area triestina. Risultati dell’arruolamento 90
Le crisi ischemiche cerebrali transitorie e prolungate (TIA e RIND) 90
Il morbo di Parkinson 88
Hematocrit value and hemoglobin concentration as possible risk factors in non-embolic acute cerebral infarcts 87
Ematocrito, emoglobina, numero di globuli rossi e bianchi in rapporto al rischio di insorgenza delle vasculopatie cerebrali acute di tipo ischemico 87
Ticlopidine and pentoxifylline in acute cerebral infarct. Clinical study on 151 patients 86
Familial nature of acute cerebral vasculopathies of the ischemic type 86
Focus on: Report dal 19° Meeting dell'European Neurological Society 85
Hematocrit and hemoglobin in the pathogenesis of transient cerebral ischemic attacks 84
Totale 13.568
Categoria #
all - tutte 44.954
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.954


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021363 0 0 0 0 0 0 0 0 0 149 64 150
2021/2022852 28 95 12 92 4 32 31 58 143 106 100 151
2022/20231.175 136 68 130 142 117 255 29 89 153 3 43 10
2023/2024761 27 29 35 57 132 44 45 236 6 33 77 40
2024/20251.799 10 95 74 170 270 211 70 96 245 115 138 305
2025/20263.996 275 399 598 489 324 384 479 161 391 496 0 0
Totale 14.614